Approximate boundaries of a 1,148bp deletion resulting from the imprecise excision of P{EP}Ctr1AG788 that removes most of the Ctr1A coding sequence. It is not clear from Fig. 2 if the deletion includes any sequences upstream from the insertion.
Heterozygous Ctr1A25 mutant flies appear to have normal cardiac function as fractional shortening (FS) is comparable to controls.
First and second instar hemizygous Ctr1A25 mutant larvae demonstrate significant pigmentation defects of the mouth hook structures and spiracles. The pigmentation defects are more severe in mutant embryos and larvae lacking both maternal and zygotic Ctr1A.
Ctr1A25 is essential for development, because hemizygous Ctr1A25 zygotic mutant larvae arrest as either 1st instar larvae (~40%) or as 2nd instar larvae ~60%). Ctr1A25 mutants lacking both maternal and zygotic Ctr1A arrest at earlier developmental stages than zygotic mutants. Approximately 40% of Ctr1A25 maternal and zygotic mutants arrest during embryogenesis, as compared with ~5% of zygotic mutants arresting at the embryonic stage. Ctr1A25 mutant larvae lacking both maternal and zygotic Ctr1A arrest earlier than the zygotic mutant larvae. However, a fraction of Ctr1A25 hemizygous zygotic mutants do survive to adulthood on food supplemented with extra copper ions. In contrast to copper, dietary zinc or iron supplements do not rescue Ctr1A25 mutants.
Ctr1A25 escaper males exhibit hypo-pigmented abdomen and thoracic bristles.
Ctr1A25 mutants are copper deficient. Heterozygous and hemizygous Ctr1A25 mutant larvae show approximately 20% and 30% reduction in copper levels, respectively.
Ctr1A25 mutant 1st instar larvae lacking both maternal and zygotic Ctr1A exhibit lower heart beat rates than wild-type controls. Dietary copper supplementation significantly elevates the heart rate of Ctr1A25 maternal and zygotic mutant 1st instar larvae.
Ctr1A25 has lethal | larval stage phenotype, suppressible by Scer\GAL4Tub.PU/Ctr1BUASp.cHa
Ctr1A25 has abnormal developmental rate | larval stage phenotype, suppressible by Scer\GAL4Tub.PU/Ctr1BUASp.cHa
Ctr1A25 has lethal | larval stage phenotype, suppressible by Scer\GAL4Tub.PU/Hsap\SLC31A1UAS.cHa
Ctr1A25 has abnormal developmental rate | larval stage phenotype, suppressible by Scer\GAL4Tub.PU/Hsap\SLC31A1UAS.cHa
Ctr1A25 has lethal phenotype, suppressible by Scer\GAL4Tub.PU/Ctr1CUAS.cSa
Ctr1A25 has lethal | larval stage phenotype, non-suppressible by Ctr1BUAS.cSa/Scer\GAL4Tub.PU
Ctr1A25 has abnormal developmental rate | larval stage phenotype, non-suppressible by Ctr1BUAS.cSa/Scer\GAL4Tub.PU
Overexpression of Ctr1BScer\UAS.cSa under the control of Scer\GAL4tub fails to suppress the lethality associated with developmental arrest found in Ctr1A25 mutants. This failure could be associated with toxicity caused by excessive copper uptake.
Overexpression of Ctr1BScer\UAS.P\T.cHa under the control of Scer\GAL4tub suppresses the lethality associated with developmental arrest found in Ctr1A25 mutants.
Expression of Ctr1CScer\UAS.cSa under the control of Scer\GAL4tub.PU can fully suppress the lethality found in Ctr1A25 mutants.
Overexpression of Hsap\CTR1Scer\UAS.cHa under the control of Scer\GAL4tub.PU suppresses the lethality associated with developmental arrest found in Ctr1A25 mutants.
Ctr1A25 is rescued by Ctr1AUAS.cHa/Scer\GAL4Tub.PU
Ctr1A25 is rescued by Ctr1AUAS.cTa